-
1
-
-
0022885040
-
Folic acid supplements in vitamin tablets: A determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia
-
Schroder H, Clausen N, Ostergard E, Pressler T. Folic acid supplements in vitamin tablets: A determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1986; 3: 241-247.
-
(1986)
Pediatr Hematol Oncol
, vol.3
, pp. 241-247
-
-
Schroder, H.1
Clausen, N.2
Ostergard, E.3
Pressler, T.4
-
2
-
-
33644820849
-
Folate during antifolate chemotherapy: What we know... and do not know
-
Robien K. Folate during antifolate chemotherapy: What we know... and do not know. Nutr Clin Pract 2005; 20: 411-422.
-
(2005)
Nutr Clin Pract
, vol.20
, pp. 411-422
-
-
Robien, K.1
-
3
-
-
0000368215
-
Antifolates
-
Chabner BA, Longo DL (eds). 2nd edn. Lippincott-Raven Publishers Philadelphia
-
Chu E, Allegra CJ. Antifolates. In: Chabner BA, Longo DL (eds). Cancer Chemotherapy and Biotherapy, 2nd edn. Lippincott-Raven Publishers: Philadelphia, 1996, pp 109-148.
-
(1996)
Cancer Chemotherapy and Biotherapy
, pp. 109-148
-
-
Chu, E.1
Allegra, C.J.2
-
4
-
-
0001531566
-
Oral complications
-
Thomas ED, Blume KG, Forman SJ (eds). 2nd edn. Blackwell Science Inc. Malden, MA
-
Schubert MM, Peterson DE, Lloid ME. Oral complications. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science Inc. Malden, MA, 1999, pp 751-763.
-
(1999)
Hematopoietic Cell Transplantation
, pp. 751-763
-
-
Schubert, M.M.1
Peterson, D.E.2
Lloid, M.E.3
-
5
-
-
20244362642
-
Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens
-
Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L et al. Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 2005; 11: 383-388.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 383-388
-
-
Cutler, C.1
Li, S.2
Kim, H.T.3
Laglenne, P.4
Szeto, K.C.5
Hoffmeister, L.6
-
6
-
-
0030822786
-
Shortage of intravenous multi-vitamin solution in the United States
-
author reply -5
-
Alloju M, Ehrinpreis MN. Shortage of intravenous multi-vitamin solution in the United States. N Engl J Med 1997; 337: 54; author reply -5.
-
(1997)
N Engl J Med
, vol.337
, pp. 54
-
-
Alloju, M.1
Ehrinpreis, M.N.2
-
7
-
-
0027980844
-
Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
-
Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E et al. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036-2043.
-
(1994)
Blood
, vol.84
, pp. 2036-2043
-
-
Clift, R.A.1
Buckner, C.D.2
Thomas, E.D.3
Bensinger, W.I.4
Bowden, R.5
Bryant, E.6
-
8
-
-
0008947293
-
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
-
Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962-968.
-
(1998)
N Engl J Med
, vol.338
, pp. 962-968
-
-
Hansen, J.A.1
Gooley, T.A.2
Martin, P.J.3
Appelbaum, F.4
Chauncey, T.R.5
Clift, R.A.6
-
9
-
-
0022624255
-
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia
-
Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735.
-
(1986)
N Engl J Med
, vol.314
, pp. 729-735
-
-
Storb, R.1
Deeg, H.J.2
Whitehead, J.3
Appelbaum, F.4
Beatty, P.5
Bensinger, W.6
-
10
-
-
15244351563
-
Hematologic aspects of myeloablative therapy and bone marrow transplantation
-
Riley RS, Idowu M, Chesney A, Zhao S, McCarty J, Lamb LS et al. Hematologic aspects of myeloablative therapy and bone marrow transplantation. J Clin Lab Anal 2005; 19: 47-79.
-
(2005)
J Clin Lab Anal
, vol.19
, pp. 47-79
-
-
Riley, R.S.1
Idowu, M.2
Chesney, A.3
Zhao, S.4
McCarty, J.5
Lamb, L.S.6
-
11
-
-
0027275165
-
A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
-
Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72: 1612-1617.
-
(1993)
Cancer
, vol.72
, pp. 1612-1617
-
-
Woo, S.B.1
Sonis, S.T.2
Monopoli, M.M.3
Sonis, A.L.4
-
12
-
-
0026554876
-
Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index
-
Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992; 69: 2469-2477.
-
(1992)
Cancer
, vol.69
, pp. 2469-2477
-
-
Schubert, M.M.1
Williams, B.E.2
Lloid, M.E.3
Donaldson, G.4
Chapko, M.K.5
-
13
-
-
0028946866
-
Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients
-
Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632-2638.
-
(1995)
Blood
, vol.85
, pp. 2632-2638
-
-
Radich, J.P.1
Gehly, G.2
Gooley, T.3
Bryant, E.4
Clift, R.A.5
Collins, S.6
-
14
-
-
0003844776
-
-
Institute of Medicine. Institute of Medicine, Subcommittee of Folate Other B Vitamins, and Choline: Washington, DC
-
Institute of Medicine. Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Niacin, Vitamin B12, Pantothenic acid, Biotin, and Choline. Institute of Medicine, Subcommittee of Folate, Other B Vitamins, and Choline: Washington, DC, 1998, pp 196-305.
-
(1998)
Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Niacin, Vitamin B12, Pantothenic Acid, Biotin, and Choline
, pp. 196-305
-
-
-
15
-
-
0035412398
-
Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism
-
Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J et al. Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001; 98: 231-234.
-
(2001)
Blood
, vol.98
, pp. 231-234
-
-
Ulrich, C.M.1
Yasui, Y.2
Storb, R.3
Schubert, M.M.4
Wagner, J.L.5
Bigler, J.6
-
16
-
-
2142820811
-
Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia
-
Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004; 22: 1268-1275.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1268-1275
-
-
Robien, K.1
Schubert, M.M.2
Bruemmer, B.3
Lloid, M.E.4
Potter, J.D.5
Ulrich, C.M.6
-
17
-
-
9344266353
-
Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia
-
Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B et al. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 2004; 10: 7592-7598.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7592-7598
-
-
Robien, K.1
Ulrich, C.M.2
Bigler, J.3
Yasui, Y.4
Gooley, T.5
Bruemmer, B.6
-
18
-
-
0009244929
-
The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in mice
-
JC K
-
Mead JAR, Venditti JM, Schrecker AW, Goldin A, JC K. The effect of reduced derivatives of folic acid on toxicity and antileukemic effect of methotrexate in mice. Biochem Pharmacol 1963; 12: 371-383.
-
(1963)
Biochem Pharmacol
, vol.12
, pp. 371-383
-
-
Mead, J.A.R.1
Venditti, J.M.2
Schrecker, A.W.3
Goldin, A.4
-
19
-
-
0021366007
-
Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388
-
Parchure M, Ambaye RY, Gokhale SV. Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388. Chemotherapy 1984; 30: 119-124.
-
(1984)
Chemotherapy
, vol.30
, pp. 119-124
-
-
Parchure, M.1
Ambaye, R.Y.2
Gokhale, S.V.3
-
20
-
-
0028593942
-
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial
-
Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 833-841.
-
(1994)
Ann Intern Med
, vol.121
, pp. 833-841
-
-
Morgan, S.L.1
Baggott, J.E.2
Vaughn, W.H.3
Austin, J.S.4
Veitch, T.A.5
Lee, J.Y.6
-
21
-
-
0034944211
-
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
-
van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001; 44: 1515-1524.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1515-1524
-
-
van Ede, A.E.1
Laan, R.F.2
Rood, M.J.3
Huizinga, T.W.4
van de Laar, M.A.5
van Denderen, C.J.6
-
22
-
-
84921431104
-
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
-
CD000951
-
Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2000; 2: CD000951.
-
(2000)
Cochrane Database Syst Rev
, vol.2
-
-
Ortiz, Z.1
Shea, B.2
Suarez Almazor, M.3
Moher, D.4
Wells, G.5
Tugwell, P.6
-
23
-
-
1542359519
-
Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review
-
Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology (Oxford) 2004; 43: 267-271.
-
(2004)
Rheumatology (Oxford)
, vol.43
, pp. 267-271
-
-
Whittle, S.L.1
Hughes, R.A.2
-
24
-
-
0035018652
-
Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines
-
Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol 2001; 30: 129-134.
-
(2001)
Scand J Rheumatol
, vol.30
, pp. 129-134
-
-
Endresen, G.K.1
Husby, G.2
-
25
-
-
0012040815
-
Parenteral multivitamin products; drugs for human use; drug efficacy study implementation; amendment
-
Food and Drug Administration, US Department of Health and Human Services
-
Food and Drug Administration, US Department of Health and Human Services. Parenteral multivitamin products; drugs for human use; drug efficacy study implementation; amendment. Federal Register 2000; 65: 21200-21201.
-
(2000)
Federal Register
, vol.65
, pp. 21200-21201
-
-
-
26
-
-
10744219945
-
Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer
-
Bajetta E, Celio L, Buzzoni R, Ferrari L, Marchiano A, Martinetti A et al. Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer. Ann Oncol 2003; 14: 1543-1548.
-
(2003)
Ann Oncol
, vol.14
, pp. 1543-1548
-
-
Bajetta, E.1
Celio, L.2
Buzzoni, R.3
Ferrari, L.4
Marchiano, A.5
Martinetti, A.6
-
27
-
-
0037842139
-
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma
-
Scagliotti GV, Shin DM, Kindler HL, Vasconcelles MJ, Keppler U, Manegold C et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 2003; 21: 1556-1561.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1556-1561
-
-
Scagliotti, G.V.1
Shin, D.M.2
Kindler, H.L.3
Vasconcelles, M.J.4
Keppler, U.5
Manegold, C.6
-
28
-
-
85047688457
-
Pemetrexed (Alimta): A novel multitargeted anti-folate agent
-
Adjei AA. Pemetrexed (Alimta): A novel multitargeted anti-folate agent. Expert Rev Anticancer Ther 2003; 3: 145-156.
-
(2003)
Expert Rev Anticancer Ther
, vol.3
, pp. 145-156
-
-
Adjei, A.A.1
-
29
-
-
0033966061
-
Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation
-
Roberts JD, Poplin EA, Tombes MB, Kyle B, Spicer DV, Grant S et al. Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation. Cancer Chemother Pharmacol 2000; 45: 103-110.
-
(2000)
Cancer Chemother Pharmacol
, vol.45
, pp. 103-110
-
-
Roberts, J.D.1
Poplin, E.A.2
Tombes, M.B.3
Kyle, B.4
Spicer, D.V.5
Grant, S.6
|